IL6 and central nervous system cancer: TNF‐α/NF‐κB signaling is another key inflammatory axis: TNF‐α can stimulate glial and immune cells to produce IL‐6 and activate NF‐κB, which in turn sustains STAT3 signaling, thereby enhancing glioma cell proliferation and aggressiveness [35].